The European Medicines Agency recommended the antihemorrhagic drug eltrombopag to treat forms of thrombocytopenia and ...
US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx: Brussels, Belgium Tuesday, October 15, 2024, 13:00 Hrs [IST] UCB, a global biopharmaceutical compa ...
Frost & Sullivan recently conducted an in-depth analysis of the biotech contract research organization (CRO) industry and ...
These studies are critical for assessing the bioavailability and bioequivalence of drugs, particularly nasal aerosols and sprays. The FDA's guidance on bioavailability and bioequivalence emphasizes ...
VANCOUVER, BC / ACCESSWIRE / October 7, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC ...
This came after the firm presented the proposal for grant of permission to manufacture and market of Ferric Maltol Capsules 30 mg along with bioequivalence study protocol (No. VRL-23-004, Ver-1.0, ...
New Delhi: Noting the proposed fixed-dose combination (FDC) of 24 mg extended-release (ER) Torsemide and 8 mg Dapagliflozin Tablets is not rational; the Subject Expert Committee (SEC) functional under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback